90 results
DEFA14A
HUMA
Humacyte Inc
29 Apr 24
Additional proxy soliciting materials
7:16am
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
Humacyte, Inc.
(Name of Registrant as Specified In Its Charter)
(Name … previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rule 14a-6(i)(1) and 0-11
8-K
EX-99.1
HUMA
Humacyte Inc
22 Mar 24
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
7:06am
expenses and materials expenses to support expanded research and development initiatives and our clinical trials, including the completion of our V005 Phase
8-K
EX-1.1
i39mha ta7z4zlsm
4 Mar 24
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
6:53am
424B5
9o7dg dl6
1 Mar 24
Prospectus supplement for primary offering
4:05pm
424B5
qw6bx46un2g5xhbk
29 Feb 24
Prospectus supplement for primary offering
4:11pm
424B3
p7hjtr thuxemyh7ueu
22 Jun 23
Prospectus supplement
6:50am
DEFA14A
ycv45yx4gs6
28 Apr 23
Additional proxy soliciting materials
6:46am
424B3
h5lfikgjn
9 Sep 22
Prospectus supplement
4:43pm
424B3
ajwm8iw8e4
9 Sep 22
Prospectus supplement
4:41pm